SCHEMBL8048256

SCHEMBL8048256

Cc1ccc(/C=C/c2ccncc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.59
RAB9A P51151 4/20 0.59
MAPT P10636 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
HPGD P15428 2/20 0.59
CYP1A2 P05177 2/20 0.59
KDM4E B2RXH2 2/20 0.59
MEN1 O00255 1/20 0.59
ALOX15 P16050 1/20 0.59
CASP1 P29466 1/20 0.59
HBB P68871 1/20 0.59
KMT2A Q03164 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
NFE2L2 Q16236 4/20 0.56
ALOX5 P09917 2/20 0.55
RELA Q04206 1/20 0.52
ALDH1A1 P00352 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8048257 1.00 NPC1 (0.59) NPC1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL9966009 0.87 MAPT (0.65) NPC1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL135604 0.87 MAPT (0.65) NPC1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL11055537 0.85 NPC1 (0.48) NPC1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL107198 0.84 MAPT (0.61) NPC1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL138489 0.84 MAPT (0.61) NPC1RAB9AMAPTSMN1; SMN2HPGD
(E)-1,2-Di-P-Tolylethene SCHEMBL1305582 0.84 NFE2L2 (0.74) NPC1RAB9AMAPTSMN1; SMN2HPGD
(E)-1,2-Di-P-Tolylethene SCHEMBL1793692 0.84 NFE2L2 (0.74) NPC1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL318786 0.84 NFE2L2 (0.74) NPC1RAB9AMAPTSMN1; SMN2HPGD
(E)-1,2-Di-P-Tolylethene SCHEMBL1305580 0.84 NFE2L2 (0.74) NPC1RAB9AMAPTSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3674381-B1 ORGANIC OPTICAL MATERIAL JAPAN SCIENCE & TECH AGENCY (JP) 2023-05-10 EP disclosed
EP-3041904-B1 STYRYL SULFIDE DYES BASF SE (DE) 2020-05-20 EP disclosed
US-20170189566-A1 ALPHA-SYNUCLEIN LIGANDS WASHINGTON UNIVERSITY (US) 2017-07-06 US disclosed
EP-1161555-B1 4-(4-HYDROXYSTYRYL)PYRIDINE-CONTAINING SUBSTRATES FOR AN ANALYTE DEPENDENT ENZYME ACTIVATION SYSTEM PERKINELMER LAS INC (US) 2008-01-02 EP disclosed
US-6020436-A GRAFT POLYMERIZATION THE CHROMALINE CORPORATION (US) 2000-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170189566-A1 ALPHA-SYNUCLEIN LIGANDS SNCA, PARK7, LRRK2 NPC1 382/4885RAB9A 152/4885MAPT 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.